Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yingqin Hou

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Nature Biomedical Engineering|May 1, 2024
Targeted desialylation and cytolysis of tumour cells by fusing a sialidase to a bispecific T-cell engagerZhuo Yang, Yingqin Hou, Geramie Grande, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Reshaping the tumor microenvironment by degrading glycoimmune checkpoints Siglec-7 and -9Chao Wang, Yingqin Hou, Jaroslav Zak, et al.
Nature Biomedical Engineering|September 28, 2021
Site-specific PEGylation of interleukin-2 enhances immunosuppression via the sustained activation of regulatory T cellsBo Zhang, Jiaqi Sun, Yan Wang, et al.
Molecular Therapy. Oncology|January 17, 2025
Targeting CD45 by gene-edited CAR T cells for leukemia eradication and hematopoietic stem cell transplantation preconditioningValeria M Stepanova, Dmitry V Volkov, Daria S Osipova, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Nature Biomedical Engineering|May 1, 2024
Targeted desialylation and cytolysis of tumour cells by fusing a sialidase to a bispecific T-cell engagerZhuo Yang, Yingqin Hou, Geramie Grande, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Reshaping the tumor microenvironment by degrading glycoimmune checkpoints Siglec-7 and -9Chao Wang, Yingqin Hou, Jaroslav Zak, et al.
Nature Biomedical Engineering|September 28, 2021
Site-specific PEGylation of interleukin-2 enhances immunosuppression via the sustained activation of regulatory T cellsBo Zhang, Jiaqi Sun, Yan Wang, et al.
Molecular Therapy. Oncology|January 17, 2025
Targeting CD45 by gene-edited CAR T cells for leukemia eradication and hematopoietic stem cell transplantation preconditioningValeria M Stepanova, Dmitry V Volkov, Daria S Osipova, et al.
Pageof 3